Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2019

Open Access 01-12-2019 | Metastasis | Research

The impact of histological type on the accuracy of preoperative N staging in patients with gastric cancer

Authors: Atsushi Yamamoto, Yoshihiko Kawaguchi, Kensuke Shiraishi, Hidenori Akaike, Hiroki Shimizu, Shinji Furuya, Naohiro Hosomura, Hidetake Amemiya, Hiromichi Kawaida, Makoto Sudo, Hiroshi Kono, Daisuke Ichikawa

Published in: World Journal of Surgical Oncology | Issue 1/2019

Login to get access

Abstract

Background

The low accuracy of preoperative diagnosis of lymph node metastasis in gastric cancer (GC) complicates decisions on patient indication for neoadjuvant chemotherapy.

Methods

We investigated the use of preoperative clinical diagnosis of lymph node involvement (cN) in GC patients compared with postoperative pathological diagnosis.

Results

In a series of 265 patients enrolled at the University of Yamanashi Hospital, the overall sensitivity was 44.4% and specificity was 93.4% of CT for detecting lymph node metastasis. The positive and negative predictive values were 80.0% and 73.8%, respectively. The negative predictive value was lower for undifferentiated adenocarcinoma than that for differentiated adenocarcinoma (64.9% vs. 78.7%, p = 0.034). In cT2 ≤ and cN2 ≤ GC, overdiagnosis of lymph node metastasis was significantly more frequent in patients with differentiated (50.0%) than in undifferentiated (13.3%) adenocarcinoma (p = 0.046).

Conclusions

Diagnostic accuracy of lymph node involvement depended on histological type and cT-stage. Thus, considering preoperative histological type in GC, it may be useful to decide treatment plan.
Literature
1.
go back to reference Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101:653–60.CrossRef Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101:653–60.CrossRef
2.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef
3.
go back to reference Williams JR. The ethics activities of the World Medical Association. Sci Eng Ethics. 2005;11:7–12.CrossRef Williams JR. The ethics activities of the World Medical Association. Sci Eng Ethics. 2005;11:7–12.CrossRef
4.
go back to reference Kawaguchi T, Ichikawa D, Komatsu S, Kosuga T, Kubota T, Okamoto K, Shiozaki A, Fujiwara H, Konishi H, Morimura R, et al. Impact of combination criteria of nodal counts and sizes on preoperative MDCT in advanced gastric cancer. World J Surg. 2016;40:158–64.CrossRef Kawaguchi T, Ichikawa D, Komatsu S, Kosuga T, Kubota T, Okamoto K, Shiozaki A, Fujiwara H, Konishi H, Morimura R, et al. Impact of combination criteria of nodal counts and sizes on preoperative MDCT in advanced gastric cancer. World J Surg. 2016;40:158–64.CrossRef
5.
go back to reference Yang QM, Kawamura T, Itoh H, Bando E, Nemoto M, Akamoto S, Furukawa H, Yonemura Y. Is PET-CT suitable for predicting lymph node status for gastric cancer? Hepatogastroenterology. 2008;55:782–5.PubMed Yang QM, Kawamura T, Itoh H, Bando E, Nemoto M, Akamoto S, Furukawa H, Yonemura Y. Is PET-CT suitable for predicting lymph node status for gastric cancer? Hepatogastroenterology. 2008;55:782–5.PubMed
6.
go back to reference Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12:6–22.CrossRef Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12:6–22.CrossRef
7.
go back to reference Kim DJ, Kim W. Is lymph node size a reliable factor for estimating lymph node metastasis in early gastric cancer? J Gastric Cancer. 2018;18:20–9.CrossRef Kim DJ, Kim W. Is lymph node size a reliable factor for estimating lymph node metastasis in early gastric cancer? J Gastric Cancer. 2018;18:20–9.CrossRef
8.
go back to reference Fukagawa T, Katai H, Mizusawa J, Nakamura K, Sano T, Terashima M, Ito S, Yoshikawa T, Fukushima N, Kawachi Y, et al. A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A). Gastric Cancer. 2018;21:68–73.CrossRef Fukagawa T, Katai H, Mizusawa J, Nakamura K, Sano T, Terashima M, Ito S, Yoshikawa T, Fukushima N, Kawachi Y, et al. A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A). Gastric Cancer. 2018;21:68–73.CrossRef
9.
go back to reference Shimada H, Okazumi S, Koyama M, Murakami K. Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of (1)(8)F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature. Gastric Cancer. 2011;14:13–21.CrossRef Shimada H, Okazumi S, Koyama M, Murakami K. Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of (1)(8)F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature. Gastric Cancer. 2011;14:13–21.CrossRef
10.
go back to reference Iwasaki Y, Sasako M, Yamamoto S, Nakamura K, Sano T, Katai H, Tsujinaka T, Nashimoto A, Fukushima N, Tsuburaya A. Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol. 2013;107:741–5.CrossRef Iwasaki Y, Sasako M, Yamamoto S, Nakamura K, Sano T, Katai H, Tsujinaka T, Nashimoto A, Fukushima N, Tsuburaya A. Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol. 2013;107:741–5.CrossRef
11.
go back to reference Ito S, Sano T, Mizusawa J, Takahari D, Katayama H, Katai H, Kawashima Y, Kinoshita T, Terashima M, Nashimoto A, et al. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. Gastric Cancer. 2017;20:322–31.CrossRef Ito S, Sano T, Mizusawa J, Takahari D, Katayama H, Katai H, Kawashima Y, Kinoshita T, Terashima M, Nashimoto A, et al. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. Gastric Cancer. 2017;20:322–31.CrossRef
12.
go back to reference Japanese Gastric Cancer Association. Gastric Cancer Treatment Guidelines 2018. Tokyo: Kanehara; 2018. Japanese Gastric Cancer Association. Gastric Cancer Treatment Guidelines 2018. Tokyo: Kanehara; 2018.
13.
go back to reference Teranaka R, Takiguchi N, Ikeda A, Souda H, Tonooka T, Hoshino I, Nabeya Y. Clinicopathological examination of differentiated gastric cancer. Gan To Kagaku Ryoho. 2018;45:551–3.PubMed Teranaka R, Takiguchi N, Ikeda A, Souda H, Tonooka T, Hoshino I, Nabeya Y. Clinicopathological examination of differentiated gastric cancer. Gan To Kagaku Ryoho. 2018;45:551–3.PubMed
Metadata
Title
The impact of histological type on the accuracy of preoperative N staging in patients with gastric cancer
Authors
Atsushi Yamamoto
Yoshihiko Kawaguchi
Kensuke Shiraishi
Hidenori Akaike
Hiroki Shimizu
Shinji Furuya
Naohiro Hosomura
Hidetake Amemiya
Hiromichi Kawaida
Makoto Sudo
Hiroshi Kono
Daisuke Ichikawa
Publication date
01-12-2019
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2019
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1674-9

Other articles of this Issue 1/2019

World Journal of Surgical Oncology 1/2019 Go to the issue